1-11 of 11
Jay L. Patel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treatment Patterns and Outcomes of Patients with Acute Myeloid Leukemia (AML) from 2013 to 2022: A Connect ® Myeloid Registry Study

David L. Grinblatt, Gail J. Roboz, Daniel A. Pollyea, Mikkael A. Sekeres, Bart L. Scott, Karen Seiter, Amer M. Zeidan, Jay L. Patel, Guillermo Garcia-Manero, Rami S. Komrokji, Michael R. Savona, Irene S. Degutis, Pavel Kiselev, Edward Yu, Willem Heydendael, Ying Qiu, Sara Vergara, Ali McBride, Harry P. Erba
Journal: Blood
Blood (2023) 142 (Supplement 1): 593.
https://doi.org/10.1182/blood-2023-189963
Published: 2023
Journal Articles

Deep and Durable Cytogenetic and Molecular Responses with Pemigatinib in Myeloid/Lymphoid Neoplasms with Fibroblast Growth Factor Receptor 1 Rearrangement: The Fight-203 Study

Andreas Reiter, Jean-Jacques Kiladjian, Jay L. Patel, William Shomali, Alessandro Rambaldi, Srdan Verstovsek, Stephen Oh, Kensuke Usuki, Claire N Harrison, Ellen K. Ritchie, Luke P. Akard, Juan Carlos Hernandez Boluda, Françoise Huguet, Natalia Oliveira, Huiling Zhen, Tracy I. George, Philomena Colucci, Aidan Gilmartin, Jason Gotlib, Alessandro M. Vannucchi
Journal: Blood
Blood (2023) 142 (Supplement 1): 4551.
https://doi.org/10.1182/blood-2023-180945
Published: 2023
Journal Articles

FIGHT-203, an Ongoing Phase 2 Study of Pemigatinib in Patients With Myeloid/Lymphoid Neoplasms (MLNs) With Fibroblast Growth Factor Receptor 1 ( FGFR1 ) Rearrangement (MLN FGFR1 ): A Focus on Centrally Reviewed Clinical and Cytogenetic Responses in Previously Treated Patients

Srdan Verstovsek, Jason Gotlib, Alessandro M. Vannucchi, Alessandro Rambaldi, Andreas Reiter, William Shomali, Tracy I. George, Jay L. Patel, Philomena Colucci, Huiling Zhen, Natalia Oliveira, Jean-Jacques Kiladjian
Journal: Blood
Blood (2022) 140 (Supplement 1): 3980–3982.
https://doi.org/10.1182/blood-2022-163099
Published: 2022
Journal Articles

Preliminary Safety and Efficacy from Apex, a Phase 2 Study of Bezuclastinib (CGT9486), a Novel, Highly Selective, Potent KIT D816V Tyrosine Kinase Inhibitor, in Adults with Advanced Systemic Mastocytosis (AdvSM)

Daniel J. DeAngelo, Vinod A. Pullarkat, Miguel Piris-Villaespesa, Tracy I. George, Jay L. Patel, Celalettin Ustun, Prithviraj Bose, Mark L Heaney, Jessica Sachs, Lei Sun, Amanda Pilla, Benjamin Exter, Hina A. Jolin, Tsewang Tashi
Journal: Blood
Blood (2022) 140 (Supplement 1): 1512–1513.
https://doi.org/10.1182/blood-2022-156311
Published: 2022
Journal Articles

The genetic landscape of germline DDX41 variants predisposing to myeloid neoplasms

Peng Li, Sara Brown, Margaret Williams, Thomas White, Wei Xie, Wei Cui, Deniz Peker, Li Lei, Christian A. Kunder, Huan-You Wang, Sarah S. Murray, Jennie Vagher, Tibor Kovacsovics, Jay L. Patel
Journal: Blood
Blood (2022) 140 (7): 716–755.
https://doi.org/10.1182/blood.2021015135
Published: 2022
Includes: Supplemental data
Journal Articles

A Phase 2 Study of Pemigatinib (FIGHT-203; INCB054828) in Patients with Myeloid/Lymphoid Neoplasms (MLNs) with Fibroblast Growth Factor Receptor 1 (FGFR1) Rearrangement (MLN FGFR1 )

Jason Gotlib, Jean-Jacques Kiladjian, Alessandro Vannucchi, Alessandro Rambaldi, Andreas Reiter, William Shomali, Tracy I. George, Jay L. Patel, Philomena Colucci, Chris Walker, Huiling Zhen, Srdan Verstovsek
Journal: Blood
Blood (2021) 138 (Supplement 1): 385.
https://doi.org/10.1182/blood-2021-148103
Published: 2021
Journal Articles

Cdx Report Program: Heterogeneity Revealed in Current Reporting Practices for Hemato-Oncology Companion Diagnostic (CDx) Markers in Multiple Countries

Sabit Delic, PhD, Piers Blombery, MBBS, María José Calasanz, PhD, Devon S. Chabot-Richards, MD, Dolors Colomer, PhD, Matteo G Della Porta, MD, Paul A S Evans, PhD, Torsten Haferlach, MD, Joanne Mason, FRCPath, Jay L Patel, MD, William S. Stevenson, MBBS, PhD, Christian Thiede, MD, Maria Teresa Voso, MD, Jordan Clark
Journal: Blood
Blood (2019) 134 (Supplement_1): 5837.
https://doi.org/10.1182/blood-2019-128652
Published: 2019
Journal Articles

Disease Characteristics and Treatment of Adult Langerhans Cell Histiocytosis: A Single Center Experience

Jason Signorelli, MD PhD MBA, Sowmya Ravulapati, MBBS, Jay L Patel, MD, Michael W. Deininger, MD PhD, Srinivas K. Tantravahi, MBBS
Journal: Blood
Blood (2018) 132 (Supplement 1): 4315.
https://doi.org/10.1182/blood-2018-99-120290
Published: 2018
Journal Articles

Use of Next Generation Sequencing Panel for Routine Diagnosis of Hereditary Hemolytic Anemias

Archana M Agarwal, MD, Jay L Patel, MD, Adam Clayton, PhD, Noel Scott Reading, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2325.
https://doi.org/10.1182/blood-2018-99-112589
Published: 2018
Journal Articles

Using a Next Generation Sequencing Panel to Discover the Obscure Causes of Hereditary Hemolytic Anemias

Archana M Agarwal, MD, N. Scott Reading, PhD, Kimberly Frizzell, PhD, Wei Shen, PhD, Shelly Sorrells, PhD, Mohamed E Salama, MD, Josef T. Prchal, MD, Hassan M. Yaish, Jay L Patel, MD, Robert D. Christensen, MD
Journal: Blood
Blood (2016) 128 (22): 2433.
https://doi.org/10.1182/blood.V128.22.2433.2433
Published: 2016
Journal Articles

Targeted Detection of Copy Number Variants Using a Myeloid Malignancy Next Generation Sequencing Mutation Panel Allows Comprehensive Genetic Analysis Using a Single Testing Method

Wei Shen, PhD, Philippe Szankasi, PhD, Maria Sederberg, MS, Jonathan Schumacher, MS, Kimberly Frizzell, PhD, Elaine P Gee, PhD, Jay L Patel, MD, Sarah T. South, PhD, Xinjie Xu, PhD, Todd W Kelley, MD
Journal: Blood
Blood (2015) 126 (23): 2887.
https://doi.org/10.1182/blood.V126.23.2887.2887
Published: 2015